---
figid: PMC12240642__CPR-58-e70050-g003
figtitle: Ubiquitination‐mediated degradation of EGFR‐EGF complex and inhibition of
  downstream signalling in EGFR‐mutated cancer
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12240642
filename: CPR-58-e70050-g003.jpg
figlink: /pmc/articles/PMC12240642/figure/F1/
number: F1
caption: Ubiquitination‐mediated degradation of EGFR‐EGF complex and inhibition of
  downstream signalling in EGFR‐mutated cancer. This figure illustrates the process
  by which the ubiquitination system (E1‐E2‐E3) is activated to tag target proteins
  EGFR and GRF with ubiquitin. This tagging directs the EGFR–EGF complex to proteasomal
  degradation, thereby blocking downstream signalling pathways, such as the RAS–RAF–MEK
  signalling pathway, within cancer cells and inhibiting a variety of biological behaviours
  of cancer cells
papertitle: Mechanistic Insights and Therapeutic Potentials of Ubiquitin‐Proteasome
  System in Non‐Small Cell Lung Cancer
reftext: Guangyao Zhou, et al. Cell Prolif. 2025 Jul;58(7).
year: '2025'
doi: 10.1111/cpr.70050
journal_title: Cell Proliferation
journal_nlm_ta: Cell Prolif
publisher_name: Wiley
keywords: cancer therapy | NSCLC | proteasome inhibition | targeted therapy | ubiquitination
automl_pathway: 0.9558384
figid_alias: PMC12240642__F1
figtype: Figure
redirect_from: /figures/PMC12240642__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12240642__CPR-58-e70050-g003.html
  '@type': Dataset
  description: Ubiquitination‐mediated degradation of EGFR‐EGF complex and inhibition
    of downstream signalling in EGFR‐mutated cancer. This figure illustrates the process
    by which the ubiquitination system (E1‐E2‐E3) is activated to tag target proteins
    EGFR and GRF with ubiquitin. This tagging directs the EGFR–EGF complex to proteasomal
    degradation, thereby blocking downstream signalling pathways, such as the RAS–RAF–MEK
    signalling pathway, within cancer cells and inhibiting a variety of biological
    behaviours of cancer cells
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGF
  - EGFR
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - ATP8A2
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - STAT3
  - EGF
  - RAS
  - MEK
  - DNA
---
